CTLA4 and Huntington disease: Consistent with our previous observations (Fig. 2a, c), regulatory T cells from HD and CTLA4-variant carriers showed higher frequency and higher MFI of transendocytosis when CD80-mScarlet instead of CD80-GFP CHO cells were used (Fig. 4a, b).